Indiana University (IU) Melvin and Bren Simon Cancer Center — Indianapolis, Indiana

Indiana University (IU) Melvin and Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University (IU) Melvin and Bren Simon Cancer Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Graft-versus-host Disease (GVHD), Advanced or Metastatic Solid Tumor Malignancies, Urinary Bladder Neoplasms.

Sponsors: Incyte Corporation, Novita Pharmaceuticals, Inc., Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

• Community Regional Cancer Care at Community Hospital East
• Indiana University Health University Hospital /ID# 259827
• Riley Child & Adolescent Psychiatry Clinic- Riley Hospital
• Indiana University (IU) School of Medicine
• The Rehabilitation Hospital of Indiana
• Wishard Memorial Hospital
• Indiana University Health, Neurorehabilitation & Robotics
• Indiana University Hospital, Indiana Clinical Research Center, 550 North University Boulevard (Site 840014)
• Indiana University Health Simon Cancer Center
• Indiana University Cancer Center Clinical Research Office
• Indiana University Indiana Univ
• IU Medical Center / Riley Hospital

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University (IU) Melvin and Bren Simon Cancer Center?

Indiana University (IU) Melvin and Bren Simon Cancer Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University (IU) Melvin and Bren Simon Cancer Center conducted?

Indiana University (IU) Melvin and Bren Simon Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Graft-versus-host Disease (GVHD), Advanced or Metastatic Solid Tumor Malignancies, Urinary Bladder Neoplasms.

Is Indiana University (IU) Melvin and Bren Simon Cancer Center accredited by Crixeo Clinical Trials?

Indiana University (IU) Melvin and Bren Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University (IU) Melvin and Bren Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.